{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T16:31:43Z","timestamp":1790094703006,"version":"4.0.1"},"reference-count":60,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2005,7,1]],"date-time":"2005-07-01T00:00:00Z","timestamp":1120176000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,12,7]],"date-time":"2015-12-07T00:00:00Z","timestamp":1449446400000},"content-version":"vor","delay-in-days":3811,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Kidney International"],"published-print":{"date-parts":[[2005,7]]},"DOI":"10.1111\/j.1523-1755.2005.00398.x","type":"journal-article","created":{"date-parts":[[2005,6,13]],"date-time":"2005-06-13T04:54:37Z","timestamp":1118638477000},"page":"237-245","source":"Crossref","is-referenced-by-count":301,"title":["Biomarkers of inflammation and progression of chronickidney disease"],"prefix":"10.1016","volume":"68","author":[{"given":"Marcello","family":"Tonelli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank","family":"Sacks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Pfeffer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gian S.","family":"Jhangri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gary","family":"Curhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1111\/j.1523-1755.2005.00398.x_bb0010","first-page":"312","article-title":"Factors affecting progression in advanced chronic renal failure","volume":"39","author":"Hannedouche","year":"1993","journal-title":"Clin Nephrol"},{"key":"10.1111\/j.1523-1755.2005.00398.x_bb0015","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/S0272-6386(89)80173-8","article-title":"Progression of chronic renal failure","volume":"14","author":"Hakim","year":"1989","journal-title":"Am J Kidney Dis"},{"key":"10.1111\/j.1523-1755.2005.00398.x_bb0020","doi-asserted-by":"crossref","first-page":"1908","DOI":"10.1038\/ki.1997.260","article-title":"Predictors of the progression of renal disease in the Modification of Diet in Renal Disease Study","volume":"51","author":"Hunsicker","year":"1997","journal-title":"Kidney Int"},{"key":"10.1111\/j.1523-1755.2005.00398.x_bb0025","first-page":"301","article-title":"Factors affecting progression of renal insufficiency","volume":"23","author":"Locatelli","year":"1997","journal-title":"Miner Electrolyte Metab"},{"key":"10.1111\/j.1523-1755.2005.00398.x_bb0030","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1056\/NEJM199403313301301","article-title":"The effects of dietary protein restriction and blood-pressure control on the progression of chronic renal disease","volume":"330","author":"Klahr","year":"1994","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1523-1755.2005.00398.x_bb0035","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1056\/NEJM199309303291401","article-title":"The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus","volume":"329","year":"1993","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1523-1755.2005.00398.x_bb0040","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1056\/NEJM199311113292004","article-title":"The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy","volume":"329","author":"Lewis","year":"1993","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1523-1755.2005.00398.x_bb0045","doi-asserted-by":"crossref","first-page":"73","DOI":"10.7326\/0003-4819-135-2-200107170-00007","article-title":"Angiotensin-converting enzyme inhibitors and progression of nondiabetic renal disease. A meta-analysis of patient-level data","volume":"135","author":"Jafar","year":"2001","journal-title":"Ann Intern Med"},{"key":"10.1111\/j.1523-1755.2005.00398.x_bb0050","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1097\/01.ASN.0000068461.45784.2F","article-title":"Effect of pravastatin on loss of renal function in people with moderate chronic renal insufficiency and cardiovascular disease","volume":"14","author":"Tonelli","year":"2003","journal-title":"J Am Soc Nephrol"},{"key":"10.1111\/j.1523-1755.2005.00398.x_bb0055","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1053\/ajkd.2003.50140","article-title":"A controlled, prospective study of the effects of atorvastatin on proteinuria and progression of kidney disease","volume":"41","author":"Bianchi","year":"2003","journal-title":"Am J Kidney Dis"},{"key":"10.1111\/j.1523-1755.2005.00398.x_bb0060","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1001\/jama.279.18.1477","article-title":"Association of fibrinogen, C-reactive protein, albumin, or leukocyte count with coronary heart disease: Meta-analyses of prospective studies","volume":"279","author":"Danesh","year":"1998","journal-title":"JAMA"},{"key":"10.1111\/j.1523-1755.2005.00398.x_bb0065","doi-asserted-by":"crossref","first-page":"1867","DOI":"10.1046\/j.1523-1755.2001.00001.x","article-title":"Association between renal insufficiency and malnutrition in older adults: Results from the NHANES III","volume":"60","author":"Garg","year":"2001","journal-title":"Kidney Int"},{"key":"10.1111\/j.1523-1755.2005.00398.x_bb0070","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1161\/01.CIR.0000042700.48769.59","article-title":"Elevations of inflammatory and procoagulant biomarkers in elderly persons with renal insufficiency","volume":"107","author":"Shlipak","year":"2003","journal-title":"Circulation"},{"key":"10.1111\/j.1523-1755.2005.00398.x_bb0075","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1046\/j.1523-1755.2001.059002407.x","article-title":"End-stage renal disease, atherosclerosis, and cardiovascular mortality: Is C-reactive protein the missing link?","volume":"59","author":"Arici","year":"2001","journal-title":"Kidney Int"},{"key":"10.1111\/j.1523-1755.2005.00398.x_bb0080","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1084\/jem.190.12.1733","article-title":"C-reactive protein and complement are important mediators of tissue damage in acute myocardial infarction","volume":"190","author":"Griselli","year":"1999","journal-title":"J Exp Med"},{"key":"10.1111\/j.1523-1755.2005.00398.x_bb0085","doi-asserted-by":"crossref","first-page":"2629","DOI":"10.4049\/jimmunol.141.8.2629","article-title":"Tumor necrosis factor can induce both apoptic and necrotic forms of cell lysis","volume":"141","author":"Laster","year":"1988","journal-title":"J Immunol"},{"key":"10.1111\/j.1523-1755.2005.00398.x_bb0090","first-page":"H2535","article-title":"Administration of tumor necrosis factor-alpha in vivo depresses endothelium-dependent relaxation","volume":"266","author":"Wang","year":"1994","journal-title":"Am J Physiol"},{"key":"10.1111\/j.1523-1755.2005.00398.x_bb0095","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1093\/ndt\/16.6.1189","article-title":"Endothelial dysfunction in chronic renal failure: roles of lipoprotein oxidation and pro-inflammatory cytokines","volume":"16","author":"Bolton","year":"2001","journal-title":"Nephrol Dial Transplant"},{"key":"10.1111\/j.1523-1755.2005.00398.x_bb0100","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1038\/ki.1994.117","article-title":"Plasma levels of IL-1 beta, TNF alpha and their specific inhibitors in undialyzed chronic renal failure, CAPD and hemodialysis patients","volume":"45","author":"Pereira","year":"1994","journal-title":"Kidney Int"},{"key":"10.1111\/j.1523-1755.2005.00398.x_bb0105","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1097\/01.ASN.0000128966.55133.69","article-title":"Kidney dysfunction, inflammation, and coronary events: A prospective study","volume":"15","author":"Knight","year":"2004","journal-title":"J Am Soc Nephrol"},{"key":"10.1111\/j.1523-1755.2005.00398.x_bb0110","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1046\/j.1523-1755.2002.00637.x","article-title":"Inflammation and outcome in end-stage renal failure: Does female gender constitute a survival advantage?","volume":"62","author":"Stenvinkel","year":"2002","journal-title":"Kidney Int"},{"key":"10.1111\/j.1523-1755.2005.00398.x_bb0115","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.1056\/NEJM200106283442601","article-title":"Measurement of C-reactive protein for the targeting of statin therapy in the primary prevention of acute coronary events","volume":"344","author":"Ridker","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1523-1755.2005.00398.x_bb0120","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1056\/NEJM199610033351401","article-title":"The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels","volume":"335","author":"Sacks","year":"1996","journal-title":"N Engl J Med"},{"issue":"Suppl 1","key":"10.1111\/j.1523-1755.2005.00398.x_bb0125","first-page":"S76","article-title":"NKF-K\/DOQI Clinical Practice Guidelines for Chronic Kidney Disease","volume":"39","author":"National Kidney Foundation","year":"2002","journal-title":"Am J Kidney Dis"},{"key":"10.1111\/j.1523-1755.2005.00398.x_bb0130","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1016\/0002-9149(91)90276-Q","article-title":"Rationale and design of a secondary prevention trial of lowering normal plasma cholesterol levels after acute myocardial infarction: The Cholesterol and Recurrent Events trial (CARE)","volume":"68","author":"Sacks","year":"1991","journal-title":"Am J Cardiol"},{"key":"10.1111\/j.1523-1755.2005.00398.x_bb0135","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1093\/clinchem\/27.3.493","article-title":"A multi-rule Shewhart chart for quality control in clinical chemistry","volume":"27","author":"Westgard","year":"1981","journal-title":"Clin Chem"},{"key":"10.1111\/j.1523-1755.2005.00398.x_bb0140","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/0021-9150(93)90105-4","article-title":"Pravastatin experience in elderly and non-elderly patients","volume":"101","author":"Mellies","year":"1993","journal-title":"Atherosclerosis"},{"key":"10.1111\/j.1523-1755.2005.00398.x_bb0145","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1002\/j.1552-4604.1992.tb03816.x","article-title":"Single-dose pharmacokinetics of pravastatin and metabolites in patients with renal impairment","volume":"32","author":"Halstenson","year":"1992","journal-title":"J Clin Pharmacol"},{"key":"10.1111\/j.1523-1755.2005.00398.x_bb0150","series-title":"Applied Logistic Regression New York, Wiley Interscience","first-page":"91","article-title":"Model building strategies, chapter 4","author":"Hosmer","year":"2000"},{"key":"10.1111\/j.1523-1755.2005.00398.x_bb0155","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1111\/j.1365-2362.1990.tb01798.x","article-title":"The role of lipids in the pathogenesis of glomerulosclerosis in the rat following subtotal nephrectomy","volume":"20","author":"Rayner","year":"1990","journal-title":"Eur J Clin Invest"},{"key":"10.1111\/j.1523-1755.2005.00398.x_bb0160","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1159\/000167599","article-title":"Lipids and progressive glomerulosclerosis. A model analogous to atherosclerosis","volume":"8","author":"Keane","year":"1988","journal-title":"Am J Nephrol"},{"key":"10.1111\/j.1523-1755.2005.00398.x_bb0165","first-page":"365","article-title":"C-reactive protein frequently localizes in the kidney in glomerular diseases","volume":"55","author":"Nakahara","year":"2001","journal-title":"Clin.Nephrol"},{"key":"10.1111\/j.1523-1755.2005.00398.x_bb0170","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1161\/01.CIR.0000085568.13915.1E","article-title":"Increased thrombosis after arterial injury in human C-reactive protein-transgenic mice","volume":"108","author":"Danenberg","year":"2003","journal-title":"Circulation"},{"key":"10.1111\/j.1523-1755.2005.00398.x_bb0175","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1161\/01.CIR.0000114526.50618.24","article-title":"C-reactive protein accelerates the progression of atherosclerosis in apolipoprotein E-deficient mice","volume":"109","author":"Paul","year":"2004","journal-title":"Circulation"},{"key":"10.1111\/j.1523-1755.2005.00398.x_bb0180","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1056\/NEJM199811123392007","article-title":"Pathophysiology of progressive nephropathies","volume":"339","author":"Remuzzi","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1523-1755.2005.00398.x_bb0185","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1111\/j.1365-2249.1992.tb07948.x","article-title":"Passive immunization against tumour necrosis factor-alpha (TNF-alpha) and IL-1 beta protects from LPS enhancing glomerular injury in nephrotoxic nephritis in rats","volume":"90","author":"Karkar","year":"1992","journal-title":"Clin Exp Immunol"},{"key":"10.1111\/j.1523-1755.2005.00398.x_bb0190","first-page":"419","article-title":"Tumor necrosis factor induces glomerular damage in the rabbit","volume":"134","author":"Bertani","year":"1989","journal-title":"Am J Pathol"},{"key":"10.1111\/j.1523-1755.2005.00398.x_bb0195","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1093\/ndt\/16.3.518","article-title":"Prevention and treatment of experimental crescentic glomerulonephritis by blocking tumour necrosis factor-alpha","volume":"16","author":"Karkar","year":"2001","journal-title":"Nephrol Dial Transplant"},{"key":"10.1111\/j.1523-1755.2005.00398.x_bb0200","first-page":"272","article-title":"Tumor necrosis factor production by glomerular macrophages in anti-glomerular basement membrane glomerulonephritis in rabbits","volume":"65","author":"Tipping","year":"1991","journal-title":"Lab Invest"},{"key":"10.1111\/j.1523-1755.2005.00398.x_bb0205","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1126\/science.3933111","article-title":"Recombinant human tumor necrosis factor-alpha: Effects on proliferation of normal and transformed cells in vitro","volume":"230","author":"Sugarman","year":"1985","journal-title":"Science"},{"key":"10.1111\/j.1523-1755.2005.00398.x_bb0210","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1097\/01.ASN.0000073902.38428.33","article-title":"Intrinsic renal cells are the major source of tumor necrosis factor contributing to renal injury in murine crescentic glomerulonephritis","volume":"14","author":"Timoshanko","year":"2003","journal-title":"J Am Soc Nephrol"},{"key":"10.1111\/j.1523-1755.2005.00398.x_bb0215","first-page":"1625","article-title":"Prevention of crescentic glomerulonephritis induced by anti-glomerular membrane antibody in tumor necrosis factor-deficient mice","volume":"78","author":"Le Hir","year":"1998","journal-title":"Lab Invest"},{"key":"10.1111\/j.1523-1755.2005.00398.x_bb0220","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/S0272-6386(99)70182-4","article-title":"Urinary protein excretion and serum tumor necrosis factor in diabetic patients with advanced renal failure: Effects of pentoxifylline administration","volume":"33","author":"Navarro","year":"1999","journal-title":"Am J Kidney Dis"},{"key":"10.1111\/j.1523-1755.2005.00398.x_bb0225","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S0272-6386(03)00408-6","article-title":"Inflammatory parameters are independently associated with urinary albumin in type 2 diabetes mellitus","volume":"42","author":"Navarro","year":"2003","journal-title":"Am J Kidney Dis"},{"key":"10.1111\/j.1523-1755.2005.00398.x_bb0230","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1046\/j.1523-1755.2003.00237.x","article-title":"Urinary and renal interstitial concentrations of TNF-alpha increase prior to the rise in albuminuria in diabetic rats","volume":"64","author":"Kalantarinia","year":"2003","journal-title":"Kidney Int"},{"key":"10.1111\/j.1523-1755.2005.00398.x_bb0235","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1681\/ASN.V93433","article-title":"TNF-alpha increases albumin permeability of isolated rat glomeruli through the generation of superoxide","volume":"9","author":"McCarthy","year":"1998","journal-title":"J Am Soc Nephrol"},{"key":"10.1111\/j.1523-1755.2005.00398.x_bb0240","doi-asserted-by":"crossref","first-page":"1844","DOI":"10.1016\/S0085-2538(15)48065-2","article-title":"Inflammation, not hyperhomocysteinemia, is related to oxidative stress and hemostatic and endothelial dysfunction in uremia","volume":"60","author":"Mezzano","year":"2001","journal-title":"Kidney Int"},{"key":"10.1111\/j.1523-1755.2005.00398.x_bb0245","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1007\/BF00180527","article-title":"Serum levels of the soluble receptor for tumor necrosis factor in patients with renal disease","volume":"72","author":"Halwachs","year":"1994","journal-title":"Clin Invest"},{"key":"10.1111\/j.1523-1755.2005.00398.x_bb0250","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1016\/S0272-6386(03)00353-6","article-title":"Associations between circulating inflammatory markers and residual renal function in CRF patients","volume":"41","author":"Pecoits-Filho","year":"2003","journal-title":"Am J Kidney Dis"},{"key":"10.1111\/j.1523-1755.2005.00398.x_bb0255","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1093\/ndt\/gfg080","article-title":"Impaired renal function is associated with markers of endothelial dysfunction and increased inflammatory activity","volume":"18","author":"Stam","year":"2003","journal-title":"Nephrol Dial Transplant"},{"key":"10.1111\/j.1523-1755.2005.00398.x_bb0260","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1111\/j.1523-1755.2004.00465.x","article-title":"Increased prevalence of oxidant stress and inflammation in patients with moderate to severe chronic kidney disease","volume":"65","author":"Oberg","year":"2004","journal-title":"Kidney Int"},{"key":"10.1111\/j.1523-1755.2005.00398.x_bb0265","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1046\/j.1523-1755.2002.00522.x","article-title":"Cardiovascular disease risk status in elderly persons with renal insufficiency","volume":"62","author":"Shlipak","year":"2002","journal-title":"Kidney Int"},{"key":"10.1111\/j.1523-1755.2005.00398.x_bb0270","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1046\/j.1523-1755.2003.00762.x","article-title":"C-reactive protein is associated with renal function abnormalities in a non-diabetic population","volume":"63","author":"Stuveling","year":"2003","journal-title":"Kidney Int"},{"key":"10.1111\/j.1523-1755.2005.00398.x_bb0275","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S0272-6386(00)70296-4","article-title":"Activation of the acute phase response and complement C3 in patients with IgA nephropathy","volume":"35","author":"Janssen","year":"2000","journal-title":"Am J Kidney Dis"},{"key":"10.1111\/j.1523-1755.2005.00398.x_bb0280","doi-asserted-by":"crossref","first-page":"2208","DOI":"10.1046\/j.1523-1755.2002.00677.x","article-title":"Serum C-reactive protein and leptin as predictors of kidney disease progression in the Modification of Diet in Renal Disease Study","volume":"62","author":"Sarnak","year":"2002","journal-title":"Kidney Int"},{"key":"10.1111\/j.1523-1755.2005.00398.x_bb0285","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/S0021-9150(02)00378-7","article-title":"Does pravastatin affect circulating levels of soluble TNF receptor 2 in hypercholesterolemic patients?","volume":"166","author":"Ando","year":"2003","journal-title":"Atherosclerosis"},{"key":"10.1111\/j.1523-1755.2005.00398.x_bb0290","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/S0021-9150(00)00725-5","article-title":"Reduced levels of TNF alpha in hypercholesterolemic individuals after treatment with pravastatin for 8 weeks","volume":"157","author":"Solheim","year":"2001","journal-title":"Atherosclerosis"},{"key":"10.1111\/j.1523-1755.2005.00398.x_bb0295","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1046\/j.1523-1755.2002.00600.x","article-title":"The elephant in uremia: Oxidant stress as a unifying concept of cardiovascular disease in uremia","volume":"62","author":"Himmelfarb","year":"2002","journal-title":"Kidney Int"},{"key":"10.1111\/j.1523-1755.2005.00398.x_bb0300","doi-asserted-by":"crossref","first-page":"2214","DOI":"10.1046\/j.1523-1755.1999.00773.x","article-title":"Cardiovascular disease and mortality in a community-based cohort with mild renal insufficiency","volume":"56","author":"Culleton","year":"1999","journal-title":"Kidney Int"},{"key":"10.1111\/j.1523-1755.2005.00398.x_bb0305","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1161\/01.CIR.0000079224.46084.C2","article-title":"Habitual dietary intake of n-3 and n-6 fatty acids in relation to inflammatory markers among US men and women","volume":"108","author":"Pischon","year":"2003","journal-title":"Circulation"}],"container-title":["Kidney International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0085253815508314?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0085253815508314?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,5,3]],"date-time":"2023-05-03T06:54:09Z","timestamp":1683096849000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0085253815508314"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,7]]},"references-count":60,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2005,7]]}},"alternative-id":["S0085253815508314"],"URL":"https:\/\/doi.org\/10.1111\/j.1523-1755.2005.00398.x","relation":{},"ISSN":["0085-2538"],"issn-type":[{"value":"0085-2538","type":"print"}],"subject":[],"published":{"date-parts":[[2005,7]]}}}